Plunkett Research Online: AVEO Pharmaceuticals Inc

AVEO PHARMACEUTICALS INC (AVEO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth .....



AVEO Pharmaceuticals Inc
Ticker: AVEO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 857-400-0101
Fax:
Address: 30 Winter Street
Boston, MA 02108 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs (Pharmaceuticals), Discovery & Manufacturing
Biopharmaceuticals
Drug Development
Drug Commercialization
Oncology
Contacts Description
Michael Bailey CEO/Director/President
Erick Lucera CFO/Chief Accounting Officer
See More
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth .....See More See More

Auditor: EY
Legal Advisor: Wilmer Cutler Pickering Hale and Dorr LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
FOTIVDA
Tivozanib
AV-380
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: